Literature DB >> 3205484

Contraceptive practice in New Zealand.

C Paul1, D C Skegg, J Smeijers, G F Spears.   

Abstract

A survey of contraceptive practice in New Zealand was carried out using a population-based sample of women, aged 25 to 54, selected as control subjects in a national case-control study. The results showed that sterilisation has become the most common means of family limitation. Overall, 45% of women aged 25 to 54 were in a union where one or the other partner had been sterilised. Vasectomy was the most common method of contraceptive sterilisation. The frequency of hysterectomy contributed to the high rates of sterilisation; 12% of women had had a hysterectomy. Over 80% of New Zealand women had used an oral contraceptive at some time, but only 11% were using the pill at the time of the survey. Comparison with earlier studies of contraceptive use in New Zealand show there has been a marked increase in the prevalence of contraceptive sterilisation, and a marked decrease in the use of oral contraceptives.

Entities:  

Keywords:  Age Distribution; Age Factors; Contraception; Contraceptive Methods; Contraceptive Prevalence Surveys; Contraceptive Usage--changes; Demographic Factors; Developed Countries; Economic Factors; Family Planning; Family Planning Surveys; Female Sterilization; Gynecologic Surgery; Hysterectomy; Male Sterilization; Marital Status; Measurement; New Zealand; Nuptiality; Oceania; Oral Contraceptives; Population; Population Characteristics; Prevalence; Research Methodology; Socioeconomic Factors; Socioeconomic Status; Sterilization, Sexual; Surgery; Treatment; Urogenital Surgery

Mesh:

Substances:

Year:  1988        PMID: 3205484

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  5 in total

Review 1.  Fortnightly review. Medical management of menorrhagia.

Authors:  A Prentice
Journal:  BMJ       Date:  1999-11-20

2.  Biosocial determinants of hysterectomy in New Zealand.

Authors:  A Dharmalingam; I Pool; J Dickson
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

3.  Medical management of menorrhagia.

Authors:  A Prentice
Journal:  West J Med       Date:  2000-04

Review 4.  Injectable contraception with depot medroxyprogesterone acetate. Current status.

Authors:  Andrew M Kaunitz; Allan Rosenfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

5.  Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer.

Authors:  C Paul; D C Skegg; G F Spears
Journal:  BMJ       Date:  1989-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.